HLA-DRA抗原；HLA-DRA重组蛋白多种属

Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)

Ⅱ类主要组织相容性复合体DRα(HLA-DRA)重组蛋白

[ PROPERTIES ]

Source: Prokaryotic expression

Host: E.coli

Residues: Lys27~Glu216

Tags: N-terminal His Tag

Subcellular Location: Lysosome, Golgi apparatus, Endoplasmic reticulum lumen

Purity: > 97%

Traits: Freeze-dried powder

Buffer formulation: PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose andProclin300.

Original Concentration: 200µg/mL

Applications: Positive Control; Immunogen; SDS-PAGE; WB.

(May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 4.4

Predicted Molecular Mass: 23.5kDa

Accurate Molecular Mass: 20kDa as determined by SDS-PAGE reducing conditions.

[ USAGE ]

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles.

             Store at 2-8ºC for one month.

             Aliquot and store at -80ºC for 12 months.

Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

[SEQUENCE ]

[  IDENTIFICATION  ]

[ IMPORTANT NOTE ]

The kit is designed for research use only, we will not be responsible for any issue if the kit was used in clinical diagnostic or any other procedures.

特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!以实际收货产品说明书为准,网站说明书仅供参考！